Medtronic's MiniMed 670G - the closest thing yet to an artificial pancreas - has been launched in the US. The so-called 'hybrid closed-loop' system comprises a blood glucose sensor ...

Most recently, market leader Medtronic launched its MiniMed 670G - the first 'hybrid closed loop' device to be approved in the US. This partially automates the monitoring of blood glucose levels ...

Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...

Medtronic is offering a peek into its ongoing, at-home trial of people with Parkinson’s disease being treated with adaptive ...

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price ...

Earlier, in May 2024, Medtronic’s MiniMed 780G system was recognized in the Best World-Changing Idea, North America category ...

Medtronic (NYSE: MDT) today announced the publication of its novel approach to studying adaptive deep brain stimulation (aDBS ...

Medtronic (NYSE: MDT) has named Jorie Soskin as its new VP and GM of its TAVR and Congenital Heart businesses.

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) ...

A month has gone by since the last earnings report for Medtronic (MDT). Shares have added about 0.7 ... U.S. revenues grew in the mid-teens on the continued adoption of the MiniMed 780G automated ...

The recent boost is partly due to Medtronic's newest insulin pump, the MiniMed 780G, which earned clearance in the U.S. in April 2023. One of this device's biggest perks is that it features an ...

Medtronic faced challenges, including poor focus, lack of innovation, and COVID-19 impact, leading to share price stagnation since 2018. Despite recent improvements in performance, Medtronic ...